RxDoctor Payments Data

Kathrine Lohrfink

Nurse Practitioner · Central Point, ORNPI 1285996405

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $2,300 of the $3,511 with a category attached, or 65.5%. Eli Lilly accounts for 65.5% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $2,571, more than ten times the $35 reported in 2021. Among nurse practitioner clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,511in general payments, 2019–2025

Across 25 payments — averaging $140.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$2K
  • Novo Nordisk$586
  • Lilly USA, LLC$195
  • AbbVie$121
  • Regeneron Healthcare Solutions, Inc.$62
  • Takeda Pharmaceuticals U.S.A., Inc.$61
  • plus $186 from 5 others

What the payments were for

  • Consulting fees$2,30066%
  • Food & beverage$1,21134%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,511 in reported general payments places this provider in the 95th percentile of 997 nurse practitioner providers in Oregon.

See all nurse practitioner providers in Oregon

Medicare billing

Part B allowed, 2024
$42,290
Medicare patients
237
Services billed
433

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc15$1,468
Albuterol Sulfate HfaAlbuterol Sulfate18$620
Bupropion XlBupropion Hcl38$537
Atorvastatin Calcium43$420
Omeprazole25$390
Levothyroxine Sodium39$355
Losartan Potassium23$302
Lisinopril39$244
Tamsulosin Hcl11$233
Simvastatin26$216
Gabapentin12$178
Montelukast Sodium15$171
Fluticasone Propionate13$164
Amlodipine Besylate30$151
Hydrochlorothiazide29$141

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Central Point

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →